# Nplate

NDC: 55513-221
Generic name: romiplostim
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20080825

FDA application: BLA125268

## Active ingredients

- ROMIPLOSTIM: 250 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-221"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-221
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c45f9a58-37c1-4f76-8e36-97d38c577037